Outcomes of axitinib versus sunitinib as first‐line therapy to patients with metastatic renal cell carcinoma in the immune‐oncology era

Kazuyuki Numakura, Tomonori Habuchi, Sei Naito et al.|Cancer Medicine|2021

Cited by 22